编辑视角。慢性肾病贫血患者的血红蛋白目标值是否应该改变？ - Suppr | 超能文献

Editorial perspective. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?

作者信息

Parfrey Patrick S

出版信息

Am J Nephrol. 2010;31(6):565-6. doi: 10.1159/000313894. Epub 2010 May 21.

DOI:10.1159/000313894

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Editorial perspective. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?编辑视角。慢性肾病贫血患者的血红蛋白目标值是否应该改变？

Am J Nephrol. 2010;31(6):565-6. doi: 10.1159/000313894. Epub 2010 May 21.

2

Debate: PRO Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?辩论：正方立场。慢性肾病贫血患者的血红蛋白目标值是否应该改变？

Am J Nephrol. 2010;31(6):552-6; discussion 563-4. doi: 10.1159/000314628. Epub 2010 May 21.

3

Debate: CON Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?辩论：反方立场。慢性肾病贫血患者的血红蛋白目标是否应该改变？

Am J Nephrol. 2010;31(6):557-60; discussion 561-2. doi: 10.1159/000314629. Epub 2010 May 21.

4

The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.美国食品药品监督管理局对治疗慢性肾脏病贫血时血红蛋白快速上升风险的看法：何去何从。

Clin J Am Soc Nephrol. 2010 Apr;5(4):553-6. doi: 10.2215/CJN.00490110. Epub 2010 Mar 4.

5

Does TREAT give the boot to ESAs in the treatment of CKD anemia?在慢性肾脏病贫血的治疗中，TREAT是否会淘汰促红细胞生成素类药物？

J Am Soc Nephrol. 2010 Jan;21(1):2-6. doi: 10.1681/ASN.2009111127. Epub 2009 Dec 24.

6

Triumph and tragedy: anemia management in chronic kidney disease.胜利与悲剧：慢性肾脏病的贫血管理

Curr Opin Nephrol Hypertens. 2008 Nov;17(6):580-8. doi: 10.1097/MNH.0b013e32830c488d.

7

The treatment of anemia in chronic kidney disease: understandings in 2006.慢性肾脏病贫血的治疗：2006年的认识

Curr Opin Nephrol Hypertens. 2007 May;16(3):267-71. doi: 10.1097/MNH.0b013e32805b7257.

8

Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.反对对所有患者一视同仁：来自美国食品药品监督管理局咨询委员会会议的教训。

J Am Soc Nephrol. 2011 Jan;22(1):1-2. doi: 10.1681/ASN.2010111133. Epub 2010 Dec 16.

9

Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.慢性肾脏病中使用促红细胞生成素纠正贫血试验不良结局的潜在机制。

Nephrol Dial Transplant. 2009 Apr;24(4):1082-8. doi: 10.1093/ndt/gfn601. Epub 2008 Nov 5.

10

Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.接受促红细胞生成素α治疗的慢性肾脏病贫血患者血红蛋白水平与生活质量的关系

Curr Med Res Opin. 2006 Oct;22(10):1929-37. doi: 10.1185/030079906X132541.